MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

13 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 281.73 millions against Rs. 287.63 millions recorded during the year-ago period.The Company has registered profit of Rs. 116.92  millions for the quarter ended March 2023, a growth of 19.46%  over Rs. 97.87 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 163.25 millions from the corresponding previous quarter of 145.88 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 281.73 287.63 -2.05 1489.73 1148.54 29.71 1489.73 1148.54 29.71
Other Income 13.99 15.09 -7.29 60.24 40.50 48.74 60.24 40.50 48.74
PBIDT 163.25 145.88 11.91 802.42 620.96 29.22 802.42 620.96 29.22
Interest 0.25 1.79 -86.03 2.01 8.28 -75.72 2.01 8.28 -75.72
PBDT 163.00 144.09 13.12 800.41 612.68 30.64 800.41 612.68 30.64
Depreciation 7.69 5.44 41.36 25.76 22.33 15.36 25.76 22.33 15.36
PBT 155.31 138.65 12.02 774.65 590.35 31.22 774.65 590.35 31.22
TAX 38.39 40.78 -5.86 194.96 154.10 26.52 194.96 154.10 26.52
Deferred Tax 0.05 0.62 -91.94 2.55 0.72 254.17 2.55 0.72 254.17
PAT 116.92 97.87 19.46 579.69 436.25 32.88 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 57.95 50.72 14.25 53.86 54.07 -0.37 53.86 54.07 -0.37
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..